Theratechnologies Q3 2024 Sales $22.600M Miss $23.981M Estimate
Portfolio Pulse from Benzinga Newsdesk
Theratechnologies reported Q3 2024 sales of $22.6 million, missing the estimated $23.981 million.
October 10, 2024 | 11:32 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Theratechnologies reported Q3 2024 sales of $22.6 million, which fell short of the $23.981 million estimate. This earnings miss could negatively impact investor sentiment and the stock price in the short term.
The reported sales figure of $22.6 million is below the expected $23.981 million, indicating a performance shortfall. Such earnings misses typically lead to negative investor sentiment and potential short-term declines in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100